Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial.
Watanabe T, Ajioka Y, Matsumoto T, Tomotsugu N, Takebayashi T, Inoue E, Iizuka B, Igarashi M, Iwao Y, Ohtsuka K, Kudo SE, Kobayashi K, Sada M, Matsumoto T, Hirata I, Murakami K, Nagahori M, Watanabe K, Hida N, Ueno F, Tanaka S, Watanabe M, Hibi T. Watanabe T, et al. Among authors: matsumoto t. J Gastroenterol. 2011 Jan;46 Suppl 1:11-6. doi: 10.1007/s00535-010-0327-0. Epub 2010 Nov 2. J Gastroenterol. 2011. PMID: 21038106 Clinical Trial.
Three cases of primary sclerosing cholangitis associated with ulcerative colitis; diagnostic usefulness of magnetic resonance cholangiopancreatography.
Oshitani N, Iimuro M, Kawashima D, Inagawa M, Sogawa M, Jinno Y, Yamagami H, Hamasaki N, Sawa Y, Hara J, Nakamura S, Matsumoto T, Seki S, Arakawa T, Kitano A, Kuroki T. Oshitani N, et al. Among authors: matsumoto t. Hepatogastroenterology. 2002 Mar-Apr;49(44):317-21. Hepatogastroenterology. 2002. PMID: 11995441
Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial.
Bamba T, Shimoyama T, Sasaki M, Tsujikawa T, Fukuda Y, Koganei K, Hibi T, Iwao Y, Munakata A, Fukuda S, Matsumoto T, Oshitani N, Hiwatashi N, Oriuchi T, Kitahora T, Utsunomiya T, Saitoh Y, Suzuki Y, Nakajima M. Bamba T, et al. Among authors: matsumoto t. Eur J Gastroenterol Hepatol. 2003 Feb;15(2):151-7. doi: 10.1097/00042737-200302000-00008. Eur J Gastroenterol Hepatol. 2003. PMID: 12560759 Clinical Trial.
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: matsumoto t. Inflamm Bowel Dis. 2012 Aug;18(8):1480-7. doi: 10.1002/ibd.21886. Epub 2011 Oct 10. Inflamm Bowel Dis. 2012. PMID: 21987418
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.
Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Ueno F, et al. Among authors: matsumoto t. J Gastroenterol. 2013 Jan;48(1):31-72. doi: 10.1007/s00535-012-0673-1. Epub 2012 Oct 23. J Gastroenterol. 2013. PMID: 23090001 Free PMC article.
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Sato N, Yoshinari T, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: matsumoto t. J Gastroenterol. 2014 Feb;49(2):254-62. doi: 10.1007/s00535-013-0807-0. Epub 2013 Apr 20. J Gastroenterol. 2014. PMID: 23604570 Clinical Trial.
Use of capsule endoscopy in patients with Crohn's disease in Japan: a multicenter survey.
Esaki M, Matsumoto T, Watanabe K, Arakawa T, Naito Y, Matsuura M, Nakase H, Hibi T, Matsumoto T, Nouda S, Higuchi K, Ohmiya N, Goto H, Kurokawa S, Motoya S, Watanabe M. Esaki M, et al. Among authors: matsumoto t. J Gastroenterol Hepatol. 2014 Jan;29(1):96-101. doi: 10.1111/jgh.12411. J Gastroenterol Hepatol. 2014. PMID: 24354993
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).
Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Abukawa D, Hisamatsu T; J-COSMOS group. Nakase H, et al. Among authors: matsumoto t. J Gastroenterol. 2022 Mar;57(3):174-184. doi: 10.1007/s00535-022-01851-1. Epub 2022 Jan 28. J Gastroenterol. 2022. PMID: 35089397 Free PMC article.
10,268 results
You have reached the last available page of results. Please see the User Guide for more information.